Sato [122], in a recent study on 22 cases of PTC, concluded that BRAF V600E, when detected in pre-surgery plasma is indicative of a high fraction of BRAF V600E in the tumor, and extrathyroidal extension. The gene discussed is BRAF; the disease is neoplasm.